HighCape Capital is a growth equity fund based in Baltimore, Maryland. Founded in 2013, the firm specializes in investing in companies that are commercializing high-margin life sciences products. Their goal is to transform outstanding medical technology companies into sustainable businesses through their multidisciplinary team of experienced executives. HighCape Capital adopts a broad investment strategy that includes early stage venture, late stage venture, post-IPO, and seed investments. As of now, they have made 15 investments with 3 successful exits. Recent funding efforts include supporting companies like Modifi Bio and Elutia.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions